Australia markets open in 5 hours 37 minutes

    -1.30 (-0.02%)

    +0.0029 (+0.39%)
  • ASX 200

    +5.30 (+0.07%)
  • OIL

    -1.88 (-2.22%)
  • GOLD

    +4.30 (+0.24%)

    -4,611.95 (-5.54%)
  • CMC Crypto 200

    -53.85 (-3.65%)

Urea Breath Test Market to Surpass US$ 157.2 Million by 2028, Says Coherent Market Insights (CMI)

·4-min read

SEATTLE, Sept. 24, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global urea breath test market is estimated to be valued at US$ 110.7 million in 2021 and is expected to exhibit a CAGR of 5.1% during the forecast period (2021-2028).

Key Trends and Analysis of the Global Urea Breath Test Market:

Key trends in the market include increasing prevalence of Helicobacter pylori infection, increasing product approvals by the regulatory authorities, and inorganic activities such as acquisitions, mergers, collaborations, and others.

Helicobacter pylori infection is amongst the most common chronic bacterial infections in humans affecting around 4.4 billion people worldwide, with a high prevalence rate of 28% to 84% in different geographic regions. Generally, the prevalence of the infection is more common in developing countries such as India and Brazil.

The increasing product approvals by the regulatory authorities is expected to aid in the growth of the global urea breath test market over the forecast period. For instance, in February 2020, Gulf Coast Scientific, Inc., a manufacturer of medical products, announced that it received the U.S. Food and Drug Administration (FDA) for Pylo Plus UBT System. Pylo Plus UBT System is a 13C urea breath test, designed to detect Helicobacter pylori (H. pylori) infection.

Request for Sample copy of this Report @

Increasing focus of market players in market strategies such as acquisitions and partnerships is expected to drive the growth of the global urea breath test market over the forecast period. For instance, in October 2016, MAYOLY SPINDLER, a leading pharmaceutical company, acquired Swedish laboratory Kibion, a leading manufacturer of urea breath tests methods. Through this acquisition, MAYOLY added various products such as Kibion’s C-13 Urea Breath Test, Diabact UBT, and breath sample analyzers such as Heliprobeand Kibion Dynamic in its product offering. Moreover, Kibion had a strong foothold in Hpylori detection market in countries such as the United Arab Emirates, Iran, and Germany. Hence, the acquisition has led to the product portfolio expansion of the company for detection of Helicobacter pylori.

Key Market Takeaways:

Increasing product launches and approvals, inorganic activities such as collaborations, acquisitions, and others are expected to drive growth of the global urea breath test market over the forecast period. For instance, in December 2019, Otsuka Pharmaceutical Co., Ltd. launched POConePlus Infrared Spectrophotometer for H. pylori diagnosis in Japan. The device measures the changes in the isotope ratio of carbon dioxide (13CO2 / 12CO2) present in exhaled breath for confirming the absence or presence of H. pylori.

Competitive Landscape:
Key players operating in the global urea breath test market include Mayoli Spindler (Kibion AB), Otsuka Pharmaceutical Co. Ltd., Sercon Group, Meridian Bioscience, Paladin Labs Inc., Beijing Richen- Force Science & Technology Co., Ltd., Fisher Analysen Methode GmbH (FAN), Avanos Medical, Inc., Beijing Binal Health Bio-Sci & Tech Co., Ltd, Kizlon Medical, and Gulf Coast Scientific, Inc.

Buy-Now this Research Report @

Market Segmentation:

  • Global Urea Breath Test Market, By Test Type:

    • Point-of-Care Tests (POCT)

    • Laboratory Based Test

  • Global Urea Breath Test Market, By Product:

    • Breath Analyzer

    • UBT- Kits

  • Global Urea Breath Test Market, By Method:

    • Mass Spectrometer

    • Infrared Spectrometer

    • Laser Assisted Rationalizer

  • Global Urea Breath Test Market, By End User:

    • Hospitals

    • Clinics

    • Diagnostic Centers

      • Standalone Labs

      • Private Lab Networks

  • Global Urea Breath Test Market, By Region:

    • North America

      • By Country:

        • U.S.

        • Canada

    • Latin America

      • By Country:

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • By Country:

        • U.K.

        • Germany

        • Italy

        • Spain

        • France

        • Russia

        • Rest of Europe

    • Asia Pacific

      • By Country

        • China

        • India

        • Japan

        • Australia

        • South Korea

        • ASEAN

        • Rest of Asia Pacific

    • Middle East

      • By Country:

        • GCC

        • Israel

        • Rest of Middle East

    • Africa

      • By Country/Region:

        • South Africa

        • Central Africa

        • North Africa

Related Market Intelligence Reports:

Breathalyzers Market, By Technology (Fuel Cell, Semiconductor Sensor, Infrared Absorption), By Application (Alcohol Detection, Tuberculosis Detection, Detection for H.pylori Infection, Drug Testing, Asthma Detection, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

U.K. Drug for Abuse Testing Devices Market, by Product Type (Immunoassay Analyzers, Chromatography Instruments, Breathalyzers (Semiconductor-based Breathalyzer, Infrared (IR) Based Breathalyzer, and Fuel Cell-based Breathalyzer), Oral Fluid Testing Devices, Urine Testing Devices (Drug Testing Cup, DIP Cards, and Drug Testing Cassettes) , and Consumables (Assay Kits, Calibrators and Controls, and Others)), by Sample Type (Urine, Breathe, Saliva, Hair, and Others), and by End User (Hospitals, Federal Departments, Rehabilitation Centers, Diagnostic Laboratories, Academic Institutes and Research Centers, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Follow Us: LinkedIn | Twitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: Website:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting